Cargando…

Targeting the autophagy promoted antitumor effect of T-DM1 on HER2-positive gastric cancer

Trastuzumab emtansine (T-DM1), an antibody-drug conjugate consisted of the HER2-targeted monoclonal antibody trastuzumab and the tubulin inhibitor emtansine, has shown potent therapeutic value in HER2-positive breast cancer (BC). However, a clinical trial indicated that T-DM1 exerts a limited effect...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Jinghui, Fan, Jiajun, Zeng, Xian, Nie, Mingming, Chen, Wei, Wang, Yichen, Luan, Jingyun, Zhu, Zeguo, Chang, Xusheng, Ju, Dianwen, Feng, Li, Yin, Kai
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7969610/ https://www.ncbi.nlm.nih.gov/pubmed/33731670 http://dx.doi.org/10.1038/s41419-020-03349-1

Ejemplares similares

Correction: Targeting the autophagy promoted antitumor effect of T-DM1 on HER2-positive gastric cancer
por: Zhang, Jinghui, et al.
Publicado: (2023)

Hedgehog signaling in gastrointestinal carcinogenesis and the gastrointestinal tumor microenvironment
por: Zhang, Jinghui, et al.
Publicado: (2021)

The role of autophagy in the cytotoxicity induced by trastuzumab emtansine (T-DM1) in HER2-positive breast cancer cells
por: Liu, Peipei, et al.
Publicado: (2020)

Activating Autophagy Enhanced the Antitumor Effect of Antibody Drug Conjugates Rituximab-Monomethyl Auristatin E
por: Wang, Yichen, et al.
Publicado: (2018)

IL‐22‐mediated renal metabolic reprogramming via PFKFB3 to treat kidney injury
por: Chen, Wei, et al.
Publicado: (2021)

Regulating autophagy facilitated therapeutic efficacy of the sonic Hedgehog pathway inhibition on lung adenocarcinoma through GLI2 suppression and ROS production
por: Fan, Jiajun, et al.
Publicado: (2019)

Targeting 4-1BB and PD-L1 induces potent and durable antitumor immunity in B-cell lymphoma
por: Wang, Yichen, et al.
Publicado: (2022)

Inhibition of Autophagy Potentiated the Antitumor Effect of Nedaplatin in Cisplatin-Resistant Nasopharyngeal Carcinoma Cells
por: Liu, Zhongyu, et al.
Publicado: (2015)

A novel and promising therapeutic approach for NSCLC: recombinant human arginase alone or combined with autophagy inhibitor
por: Shen, Weitao, et al.
Publicado: (2017)

Hedgehog Signaling Pathway and Autophagy in Cancer
por: Zeng, Xian, et al.
Publicado: (2018)

The role of autophagy in asparaginase-induced immune suppression of macrophages
por: Song, Ping, et al.
Publicado: (2017)

Inflammasome: A Double-Edged Sword in Liver Diseases
por: Luan, Jingyun, et al.
Publicado: (2018)

Antitumor activity of pan‐HER inhibitors in HER2‐positive gastric cancer
por: Yoshioka, Takahiro, et al.
Publicado: (2018)

Interleukin-22 drives a metabolic adaptive reprogramming to maintain mitochondrial fitness and treat liver injury
por: Chen, Wei, et al.
Publicado: (2020)

Autophagy suppression potentiates the anti-glioblastoma effect of asparaginase in vitro and in vivo
por: Chen, Qicheng, et al.
Publicado: (2017)

Interleukin-22 Attenuated Renal Tubular Injury in Aristolochic Acid Nephropathy via Suppressing Activation of NLRP3 Inflammasome
por: Wang, Shaofei, et al.
Publicado: (2019)

Tethering Interleukin-22 to Apolipoprotein A-I Ameliorates Mice from Acetaminophen-induced Liver Injury
por: Chen, Wei, et al.
Publicado: (2017)

Blocking CD47 efficiently potentiated therapeutic effects of anti-angiogenic therapy in non-small cell lung cancer
por: Zhang, Xuyao, et al.
Publicado: (2019)

NOD-Like Receptor Protein 3 Inflammasome-Dependent IL-1β Accelerated ConA-Induced Hepatitis
por: Luan, Jingyun, et al.
Publicado: (2018)

HER2 expression and efficacy of T-DM1
por: Montemurro, Filippo
Publicado: (2014)

Heregulin-expressing HER2-positive breast and gastric cancer exhibited heterogeneous susceptibility to the anti-HER2 agents lapatinib, trastuzumab and T-DM1
por: Nonagase, Yoshikane, et al.
Publicado: (2016)

Asparaginase induces apoptosis and cytoprotective autophagy in chronic myeloid leukemia cells
por: Song, Ping, et al.
Publicado: (2015)

Anti-CD47 Antibody Enhances the Efficacy of Chemotherapy in Patients with Gastric Cancer Liver Metastasis
por: Liu, Zhaorui, et al.
Publicado: (2023)

Autophagy Plays a Critical Role in ChLym-1-Induced Cytotoxicity of Non-Hodgkin’s Lymphoma Cells
por: Fan, Jiajun, et al.
Publicado: (2013)

Interleukin-22 ameliorated renal injury and fibrosis in diabetic nephropathy through inhibition of NLRP3 inflammasome activation
por: Wang, Shaofei, et al.
Publicado: (2017)

TROP2-directed nanobody-drug conjugate elicited potent antitumor effect in pancreatic cancer
por: Xu, Caili, et al.
Publicado: (2023)

Clinical efficacy and safety of T-DM1 for patients with HER2-positive breast cancer
por: Ma, Bo, et al.
Publicado: (2016)

Mechanisms of resistance to trastuzumab emtansine (T-DM1) in HER2-positive breast cancer
por: Hunter, Francis W., et al.
Publicado: (2019)

Enhanced Antitumor Effect of Trastuzumab and Duligotuzumab or Ipatasertib Combination in HER-2 Positive Gastric Cancer Cells
por: Laterza, Maria Maddalena, et al.
Publicado: (2021)

Therapeutic potential of an anti-HER2 single chain antibody–DM1 conjugates for the treatment of HER2-positive cancer
por: Zhang, Hang, et al.
Publicado: (2017)

Simultaneous blockade of VEGF-B and IL-17A ameliorated diabetic kidney disease by reducing ectopic lipid deposition and alleviating inflammation response
por: Cao, Zhonglian, et al.
Publicado: (2023)

Loss of HER2 and decreased T-DM1 efficacy in HER2 positive advanced breast cancer treated with dual HER2 blockade: the SePHER Study
por: Bon, Giulia, et al.
Publicado: (2020)

YES1 amplification confers trastuzumab–emtansine (T-DM1) resistance in HER2-positive cancer
por: Wang, Lei, et al.
Publicado: (2020)

Dynamics of Endocytosis and Degradation of Antibody-Drug Conjugate T-DM1 in HER2 Positive Cancer Cells
por: Liang, Keying, et al.
Publicado: (2021)

HER2-Selective and Reversible Tyrosine Kinase Inhibitor Tucatinib Potentiates the Activity of T-DM1 in Preclinical Models of HER2-positive Breast Cancer
por: Olson, Devra, et al.
Publicado: (2023)

STAT3 activation confers trastuzumab‐emtansine (T‐DM1) resistance in HER2‐positive breast cancer
por: Wang, Lei, et al.
Publicado: (2018)

Tumor Extrinsic Factors Mediate Primary T-DM1 Resistance in HER2-Positive Breast Cancer Cells
por: Endo, Yukinori, et al.
Publicado: (2021)

Interplay of Oxidative Stress and Autophagy in PAMAM Dendrimers-Induced Neuronal Cell Death
por: Li, Yubin, et al.
Publicado: (2015)

HER2-positive gastric cancer
por: Boku, Narikazu
Publicado: (2013)

HER2 Directed Antibody-Drug-Conjugates beyond T-DM1 in Breast Cancer
por: Rinnerthaler, Gabriel, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_92qjqd3pj5lreocjk7lfsidm8u